RecruitingNCT06726590

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

The Texas Interprofessional Pharmacogenomics Registry and Repository


Sponsor

Texas A&M University

Enrollment

3,000 participants

Start Date

Nov 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This program collects genetic and health information to help doctors choose the right medications for patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study builds a registry of patients who undergo pharmacogenomics (PGx) testing — genetic testing that predicts how your body processes medications — to understand how this testing influences prescribing decisions and patient outcomes. **You may be eligible if...** - Are eligible for pharmacogenomics (PGx) testing or PGx-guided care - Take 5 or more medications (including over-the-counter drugs, supplements, cannabis, or other recreational substances) - Able to provide consent to participate **You may NOT be eligible if...** - Are not eligible for PGx testing based on clinical assessment - Take fewer than 5 medications - Are unwilling to have genetic testing results stored in the registry Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Texas A&M Family Care

Bryan, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06726590


Related Trials